Bayer Satisfies DoJ ‘Need To Know’ About Probiotic Claim Studies
This article was originally published in The Tan Sheet
Executive Summary
A judge also grants Bayer’s request to depose an FTC attorney about the agency’s investigation that led to a contempt charge linked to allegedly violating a 2007 consent decree by making a drug claim for the Phillips’ Colon Health three-bacteria-strain formula.
You may also be interested in...
Bayer Probiotic Claim Defense Argues FTC Wants Substantiation Standard That ‘Did Not Exist’
DoJ says Bayer is avoiding answering requests for details on research that substantiates claims for Philip’s Colon Health and asks a judge to “resolve this matter.” Bayer says it has answered DoJ’s interrogatories, stating it could not comply with FTC’s alleged “standard because it did not exist until” the complaint was filed.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.